Spectral AI (MDAI) Revenue Growth (1y) (2023 - 2026)
Spectral AI (MDAI) Revenue Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn | 6.08% |
| 10 | Spectral AI | 52.09 Mn | 40.43 Mn | 2.03 Mn | -40.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.50% |
| Dec 31, 2025 | -46.27% |
| Sep 30, 2025 | -53.60% |
| Jun 30, 2025 | -32.27% |
| Mar 31, 2025 | 6.02% |
| Dec 31, 2024 | 43.82% |
| Sep 30, 2024 | 137.59% |
| Jun 30, 2024 | 75.91% |
| Mar 31, 2024 | 24.58% |
| Dec 31, 2023 | -13.27% |
| Sep 30, 2023 | -51.12% |